Cargando…
Insufficient nocturnal sleep was associated with a higher risk of fibrosis in patients with diabetes with metabolic associated fatty liver disease
BACKGROUND: Metabolic associated fatty liver disease (MAFLD) refers to metabolic dysfunction associated with fatty liver disease, and liver fibrosis stage is closely connected with liver-related and all-cause mortality. This study aimed to explore the association of sleep duration with liver fibrosi...
Autores principales: | Zheng, Jiaping, Chen, Sijie, Cai, Yuqing, Lin, Su, Ke, Sujie, Liu, Libin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493234/ https://www.ncbi.nlm.nih.gov/pubmed/32973993 http://dx.doi.org/10.1177/2042018820947550 |
Ejemplares similares
-
Association Between the Severity of Nocturnal Hypoxia in Obstructive Sleep Apnea and Non-Alcoholic Fatty Liver Damage
por: Cakmak, Erol, et al.
Publicado: (2015) -
Association of Obstructive Sleep Apnea with Nocturnal Hypoxemia in Metabolic-Associated Fatty Liver Disease Patients: A Cross-sectional Analysis of Record-based Data
por: Tomar, Arvind, et al.
Publicado: (2021) -
Association between nocturnal hypoxia and liver injury in the setting of nonalcoholic fatty liver disease
por: Lin, Qi-Chang, et al.
Publicado: (2014) -
Higher cardiovascular risk scores and liver fibrosis risk estimated by biomarkers in patients with metabolic-dysfunction-associated fatty liver disease
por: Salgado Alvarez, Giovanni Alejandro, et al.
Publicado: (2022) -
Obstructive sleep apnea and nocturnal hypoxemia in adult patients with cystic fibrosis
por: Welsner, Matthias, et al.
Publicado: (2022)